News
Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
4h
Woman's World on MSNFridays Weight Loss: Real Facts and Figures About the Online GLP-1 Prescriber With an Exclusive Brand Interview!Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions ...
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
5d
Pharmaceutical Technology on MSNEli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketingMochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Service GLP-1 Medication Platform Offering Affordable Access to Semaglutide, Tirzepatide, and Phentermine with 24/7 Coaching, ...
Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results